In order to gain a better understanding of the role of GLP-1 agonists in ALS and their potential for clinical translation we conducted in vivo pharmacology studies with liraglutide following established guidelines for preclinical testing11. The gene discussed is GLP1R; the disease is amyotrophic lateral sclerosis.